Literature DB >> 9716417

Model and simulation of multivalent binding to fixed ligands.

K M Müller1, K M Arndt, A Plückthun.   

Abstract

A model to quantitate the principal aspects of multivalent binding was developed. It describes the random distribution of an immobilized component (the ligand) taking into account local densities. The binding of a bivalent molecule (the analyte) to the ligand is described as occurring in two steps, the second of which is driven by the local concentration of neighboring ligands. The model was used to simulate the kinetics of bivalent binding in surface plasmon resonance biosensors such as BIAcore. The simulations are compared with measured data. The simulation quantitates the influence of bivalent binding on the sensor signal, as a function of ligand density, analyte concentration, and binding site distance. Such simulations will be helpful for understanding and designing experiments to assess avidity effects as well as for developing molecules with high avidity. Furthermore, they help to analyze the inherent complexity in seemingly simple sensorgrams. Copyright 1998 Academic Press.

Mesh:

Substances:

Year:  1998        PMID: 9716417     DOI: 10.1006/abio.1998.2725

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  36 in total

1.  Deletion of the proline-rich region of TonB disrupts formation of a 2:1 complex with FhuA, an outer membrane receptor of Escherichia coli.

Authors:  Cezar M Khursigara; Gregory De Crescenzo; Peter D Pawelek; James W Coulton
Journal:  Protein Sci       Date:  2005-03-31       Impact factor: 6.725

2.  Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time.

Authors:  Georges Vauquelin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-28       Impact factor: 3.000

Review 3.  Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 4.  Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo.

Authors:  Georges Vauquelin
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

Review 5.  The role of mass transport limitation and surface heterogeneity in the biophysical characterization of macromolecular binding processes by SPR biosensing.

Authors:  Peter Schuck; Huaying Zhao
Journal:  Methods Mol Biol       Date:  2010

6.  Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues.

Authors:  Maureen R Newman; Steven G Russell; Christopher S Schmitt; Ian A Marozas; Tzong-Jen Sheu; J Edward Puzas; Danielle S W Benoit
Journal:  Biomacromolecules       Date:  2017-12-28       Impact factor: 6.988

7.  Mechanisms of noncanonical binding dynamics in multivalent protein-protein interactions.

Authors:  Wesley J Errington; Bence Bruncsics; Casim A Sarkar
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-27       Impact factor: 11.205

8.  Measuring Protein Interactions by Optical Biosensors.

Authors:  Huaying Zhao; Lisa F Boyd; Peter Schuck
Journal:  Curr Protoc Protein Sci       Date:  2017-04-03

9.  Enhanced potency of bivalent small molecule gp41 inhibitors.

Authors:  Vladimir Sofiyev; Hardeep Kaur; Beth A Snyder; Priscilla A Hogan; Roger G Ptak; Peter Hwang; Miriam Gochin
Journal:  Bioorg Med Chem       Date:  2016-11-19       Impact factor: 3.641

10.  The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs.

Authors:  Lars M Joergensen; Ali Salanti; Tina Dobrilovic; Lea Barfod; Tue Hassenkam; Thor G Theander; Lars Hviid; David E Arnot
Journal:  Malar J       Date:  2010-04-19       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.